Fibroblast–matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype

Gali Epstein Shochet, Lutz Wollin, David Shitrit

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Fibroblast–matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype'. Together they form a unique fingerprint.

Medicine & Life Sciences